SMART@Home Feasibility Trial for Asthma in Teens
This study is testing a digital tool called SMART@Home to help teenagers aged 12-18 with asthma manage their condition better. The SMART@Home tool will send daily reminders for medication and diary entries, and provide educational content about managing asthma. The researchers want to see if using SMART@Home helps teens stick to their medication schedule and how often they use the app over 6 months. You might be able to join if you have asthma, are between 12 and 18 years old, and you and your caregiver speak English. The study is currently unclear about its recruitment status and plans to enroll 25 participants.
- Study design
- This is an interventional study planning to enroll 25 participants. It is not specified if it is randomized or blinded.
- What's involved
- Participants will receive daily medication and diary completion reminders through the SMART@Home tool. They will also receive additional educational content regarding self-management skills.
- Compensation
- Not stated in the trial record.
- Follow-up
- Medication adherence and app usage will be measured at 6 months.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
SMART@Home Feasibility Trial
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Kevin Hommel, PhD · PRINCIPAL_INVESTIGATOR · Children's Hospital Medical Center, Cincinnati
- Rachelle Ramsey, PhD · STUDY_CHAIR · Children's Hospital Medical Center, Cincinnati
- Matt Wortman, PhD · STUDY_CHAIR · Children's Hospital Medical Center, Cincinnati
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Medication Adherence6 months
Monthly adherence will be calculated by comparing doses taken to doses recommended by IMAAP. Participants will also report rescue medication use each month when completing the ACT.
- Number of days app used6 months
Number of diaries completed by participant